相关实验视频

Updated: May 25, 2025

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors

Published on: June 8, 2022

通过修改的氨酸-5,8-二氧化来发现斯芬哥辛激酶抑制

Ryan D Kruschel¹, Kyle Malone², Alison N Walsh¹

¹School of Chemistry and ABCRF, University College Cork, Western Road, T12K8AF Cork, Ireland.

Pharmaceuticals (Basel, Switzerland)

|February 26, 2025

概括

研究人员开发了新的氨酸-5,8-二离子化合物作为氨酸激酶 (SphK) 抑制剂. 这些化合物表现出低微分子双SphK1/2抑制,为癌症药物开发提供了新的途径.

科学领域:

药用化学医学化学
药物发现药物发现药物发现
生物化学生物化学

背景情况:

斯芬哥辛激酶 (SphK) 在各种癌症中过度表达,促进瘤生长.
SphK 抑制剂被用于癌症治疗,其中一些显示临床疗效.
现有的抑制剂,如PF-543和opaganib强调SphK作为药物标.

研究的目的:

开发第一个基于氨酸-5,8-二的斯芬戈氨酸激酶抑制剂.
使用基于片段的方法探索SphK抑制的结构-活性关系.
通过准SphK,识别具有潜在抗癌性能的新型化合物.

主要方法:

基于碎片的药物设计,使用CB5468139和PF-543作为结构导体.
新型氨酸-5,8-二衍生物的合成和表征.
针对SphK1和SphK2的体外酶分析和分子对接研究.

主要成果:

合成了8种新型C7以太结合的氨酸-5,8-二,并对SphK1/2活性进行了选.
基于pyrrolidine的衍生品,特别是21化合物,显示出更好的SphK1结合疗效.
分子建模表明,皮罗利丁氨酸氨酸-5,8-二烯基支架具有有利的对接和结合能量.

结论:

首批基于oline-5,8-dione的SphK抑制剂被确定具有低微分子双SphK1/2抑制.
阐明了SphK抑制剂潜在的新结合方式.
虽然抗癌活性查得不到结论,但确定的抑制剂代表了进一步药物开发的有希望的新化学框架.

关键词:

癌症癌症癌症癌症癌症基于碎片的设计设计.抑制酶抑制的方法奇诺林-5,8-二烯是一种斯芬戈氨酸激酶的作用

更多相关视频

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Published on: January 27, 2014

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

相关概念视频

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Phosphoinositides and PIPs

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...